Nexeon MedSystems said it licensed a portfolio of patents from Marathon Patent Group that protects innovations in the Internet of Things (IoT).
Nexeon said the 86 patents originated from Siemens.
“The data gathered in these IoT systems can be utilized to help improve the programming for implantable devices,” said Nexeon CEO Will Rosellini.
“An average patient with a chronic disease typically takes more than five different medications every day, most of which need to be taken at different times of the day and have specific dietary recommendations to accompany the dosages.
“This same patient is typically demonstrating symptoms associated with cognitive, psychiatric, and motor disorders as well.
“The promise of keeping the device in the right therapeutic range with data from the IoT is extraordinary.”
Nexeon said the portfolio’s subject matter “is directed toward self-healing control networks for building automation systems” in the hospital and the home.
“Siemens is one of the most innovative firms in the world,” Rosellini added.
“Integrating their network innovation with our patient-specific solutions will substantially reduce the burden of chronic disease.
“By addressing this unmet need, we will create tremendous value in the form of better, faster care with fewer in-office visits required, easier access to more accurate patient information, and decreased complications and undesired side effects due to more precise therapy and better monitoring.”